
浏览全部资源
扫码关注微信
河南省中医院,郑州 450002
张广玉,硕士,副主任中医师,从事中西医结合消化疾病的临床研究,E-mail:zhanggy01@126.com
孙晓娜,主任医师,从事肝胆脾胃病的临床研究,E-mail:13598009262@163.com
收稿日期:2019-04-22,
网络出版日期:2019-05-28,
纸质出版日期:2019-10-05
移动端阅览
张广玉, 张勤生, 孙晓娜, 等. 参苓白术散加减治疗抗生素相关性腹泻脾胃虚寒证的临床观察[J]. 中国实验方剂学杂志, 2019,25(19):74-79.
Guang-yu ZHANG, Qin-sheng ZHANG, Xiao-na SUI, et al. Clinical Observation of Addition and Subtraction Therapy of Shenling Baizhu San to Antibiotic-associated Diarrhea with Spleen-stomach Deficiency and Cold Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 74-79.
张广玉, 张勤生, 孙晓娜, 等. 参苓白术散加减治疗抗生素相关性腹泻脾胃虚寒证的临床观察[J]. 中国实验方剂学杂志, 2019,25(19):74-79. DOI: 10.13422/j.cnki.syfjx.20191835.
Guang-yu ZHANG, Qin-sheng ZHANG, Xiao-na SUI, et al. Clinical Observation of Addition and Subtraction Therapy of Shenling Baizhu San to Antibiotic-associated Diarrhea with Spleen-stomach Deficiency and Cold Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 74-79. DOI: 10.13422/j.cnki.syfjx.20191835.
目的:
2
探讨参苓白术散加减治疗抗生素相关性腹泻(AAD)脾胃虚寒证的疗效及对免疫功能、肠道菌群的影响。
方法:
2
随机115例患者按数字表法分为对照组57例和观察组58例。对照组采用双歧杆菌三联活菌散,2包/次,2次/d,温水冲服;蒙脱石散,1包/次,3次/d,温水冲服,并给予防止水、电解质与酸碱平衡紊乱措施,营养支持等处理。观察组在对照组治疗的基础上,给予内服参苓白术散加减,1剂/d。两组疗程均为连续治疗7 d。进行治疗前后症状评分和肠道分泌型免疫球蛋白(SIgA)检测;检测治疗前后外周血免疫球蛋白A(IgA),免疫球蛋白G(IgG),免疫球蛋白M(IgM)水平和T淋巴细胞亚群(CD3
+
,CD4
+
,CD8
+
和CD4
+
/CD8
+
),检测治疗前后粪便中粪便球杆菌,并行细菌培养,鉴定并计数双歧杆菌、乳酸杆菌、肠球菌数量;检测治疗前后二胺氧化酶(DAO)和
D
-乳酸水平。
结果:
2
经秩和检验分析,观察组临床疗效优于对照组(
Z
=2.268,
P
<
0.05);观察组主要症状、次要症状评分和脾胃虚寒证积分均低于对照组(
P
<
0.01);观察组肠道SIgA水平高于对照组(
P
<
0.01);观察组患者IgA,IgG水平均高于对照组(
P
<
0.01);观察组患者CD3
+
,CD4
+
,CD4
+
/CD8
+
均高于对照组(
P
<
0.05),CD8
+
低于对照组(
P
<
0.05);观察组患者粪便球杆菌低于对照组(
P
<
0.01),肠球菌计数低于对照组(
P
<
0.05),双歧杆菌、乳酸杆菌计数均高于对照组(
P
<
0.05);观察组患者血清DAO和
D
-乳酸水平均低于对照组(
P
<
0.01)。
结论:
2
在益生菌等常规治疗的基础上,加服参苓白术散加减治疗AAD脾胃虚寒证患者,可进一步的减轻症状,提高临床疗效,并能提高机体免疫功能,调节肠道菌群,促进肠黏膜屏障的修复。
Objective:
2
To discussed the clinical efficacy of addition and subtraction therapy of Shenling Baizhu San to antibiotic-associated diarrhea (AAD) with spleen-stomach deficiency and cold syndrome
and to investigate its effects on immune function and intestinal flora.
Method:
2
One hundred and fifteen patients were randomly divided into control group (57 cases) and observation group (58 cases) by random number table. Patients in control group got Shuangqi Ganjun Sanlian Huojun San
2 bags/time
2 times/days. Mengtuoshi San
1 bag/time
3 times/days
and they also got measures to prevent disturbance of water
electrolyte
acid-base balance and nutritional support. Based on the treatment in control group
patients in observation group also got addition and subtraction therapy of Shenling Baizhu San
1 dose/day. The course of treatment was 7 days in both groups. Before and after treatment
scores of symptoms
intestinal secretory immunoglobulin (SIgA) levels
peripheral blood immunoglobulin A (IgA)
G (IgG)
M (IgM) and T lymphocyte subsets (CD3
+
CD4
+
CD8
+
and CD4
+
/CD8
+
). Detection of bacillus faccalis in feces before and after treatment and the bacteria were cultured to identify and count bifidobacterium
lactobacillus and enterococcus. In addition
diamine oxidase (DAO) and D-lactic acid levels were detected before and after treatment.
Result:
2
In rank sum test
clinical efficacy in observation group was better than that in control group (
Z
=2.268
P
<
0.01). Scores of main symptoms
secondary symptoms
spleen-stomach deficiency and cold syndrome were lower than those in control group(
P
<
0.01). Levels of SIgA
IgA and IgG were significantly higher than those in the control group (
P
<
0.01). Levels of CD3
+
CD4
+
and CD4
+
/CD8
+
were higher than those in control group (
P
<
0.05)
while level of CD8
+
was lower than that in control group (
P
<
0.05). Bacillus in faeces was significantly lower than that in control group(
P
<
0.01). Count of enterococcus was lower than that in control group (
P
<
0.05)
while counts of bifidobacterium and lactobacillus were higher than those in control group (
P
<
0.05). In addition
levels of DAO and
D
-lactic acid were significantly lower than those in control group (
P
<
0.01).
Conclusion:
2
Based on conventional treatment
addition and subtraction therapy of Shenling Baizhu San can alleviate symptoms
improve clinical efficacy
improve immune function
regulate intestinal flora and promote the repair of intestinal mucosal barrier in the treatment of antibiotic-associated diarrhea (AAD) with spleen-stomach deficiency and cold syndrome.
蒲芳芳 , 王亚娟 , 石磊 , 等 . 重症监护室抗生素相关性腹泻流行现状与治疗 [J]. 现代预防医学 , 2015 , 42 ( 9 ): 1719-1721,1726 .
毛婷 , 李吉莹 , 王胜红 , 等 . 我国成人患者抗生素相关性腹泻危险因素的Meta分析 [J]. 中国药房 , 2018 , 29 ( 20 ): 2845 - 2850 .
朱承睿 , 马晓春 . 抗生素相关腹泻识别与处理 [J]. 中国实用外科杂志 , 2016 , 36 ( 2 ): 168 - 171 .
任维敏 . 苦寒伤胃与肠道菌群失调 [J]. 光明中医 , 2011 , 26 ( 2 ): 210 - 211 .
王思文 , 刘建利 . 用细胞学方法评价10种抗生素的寒热药性 [J]. 西安交通大学学报:医学版 , 2015 , 36 ( 3 ): 408 - 413 .
郑雅 , 刘冬梅 , 袁方 . 基于虚、毒、湿论治老年抗生素相关性腹泻 [J]. 山东中医药大学学报 , 2017 , 41 ( 6 ): 518 - 520 .
刘翠英 , 黄娟 , 施旭光 . 参苓白术散治疗脾虚泄泻证的研究进展 [J]. 江西中医药 , 2016 , 47 ( 11 ): 68 - 71 .
胡协鸣 . 参苓白术散加味治疗老年抗生素相关性腹泻40例疗效观察 [J]. 新中医 , 2016 , 48 ( 12 ): 44 - 45 .
中华人民共和国卫生部 . 医院感染诊断标准(试行) [J]. 中华医学杂志 , 2001 , 81 ( 5 ): 314 - 320 .
中华中医药学会 . 中医内科常见病诊疗指南·中医病证部分 [J]. 北京 : 中国中医药科技出版社 , 2008 : 83-86 .
陈思敏 , 毛杰 , 陈志茹 . 益生菌联合水溶性膳食纤维对老年抗生素相关性腹泻的防治效果 [J]. 天津医药 , 2018 , 46 ( 3 ): 284 - 287 .
刘毛 , 陈宇清 , 邵瑛 . 邵瑛教授治疗小儿抗生素相关性腹泻的临床经验 [J]. 中医药导报 , 2018 , 24 ( 11 ): 52 - 53 .
赵越 , 刘明 , 庞永城 , 等 . 菌黄保肠合剂治疗抗生素相关性腹泻脾虚湿盛型临床体会 [J]. 亚太传统医药 , 2017 , 13 ( 16 ): 99 - 100 .
李云虎 , 姚卫海 . 辨证分型治疗抗生素相关性腹泻 [J]. 中医杂志 , 2014 , 55 ( 17 ): 1509 - 1510 .
辜沅 , 舒青龙 . 基于肠道微生态的参苓白术散药理研究进展 [J]. 时珍国医国药 , 2018 , 29 ( 3 ): 674 - 676 .
王彦芳 , 韩晓春 , 王媛 , 等 . 参苓白术散对脾虚水湿不化模型大鼠健脾功效的研究 [J]. 中华中医药学刊 , 2019 , 37 ( 1 ): 60 - 63 .
王丹 , 李桂凌 , 郑诗华 . 儿宝颗粒对脾虚泻小儿免疫功能影响的观察 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 11 ): 241 - 250 .
舒青龙 , 王萍 , 封勇 , 等 . 理中汤对抗生素相关性腹泻模型构建中肠道菌群变化的影响 [J]. 中国实验方剂学杂志 , 2015 , 21 ( 21 ): 82 - 87 .
韩正贵 , 陆江涛 , 王文静 , 等 . 宣肺通腑汤辅助治疗中老年重症肺炎合并胃肠功能障碍的临床观察 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 16 ): 188 - 193 .
0
浏览量
13
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621